$4,650.16 consulting Payment -- Allergan (AbbVie) to Dr. William Lee
Plastic Surgeon Receives $4,650.16 Consulting Fee from Allergan for Ozempic-Related Services
This page provides a detailed analysis of a $4,650.16 consulting payment from Allergan (AbbVie) to Dr. William Lee. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $4,650.16 |
| Payment Type | consulting |
| Payment Nature | Consulting Fee |
| Pharmaceutical Company | Allergan (AbbVie) |
| Physician | Dr. William Lee |
| NPI Number | 1795237800 |
| Physician Specialty | Plastic Surgery |
| Location | Springfield, MA |
| Date of Payment | 2025-08-30 |
| Related Drug/Device | Ozempic |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Allergan (AbbVie) made a $4.7K consulting payment to William Lee, a Plastic Surgery specialist in Springfield, MA. The payment was associated with Ozempic. The payment of $4,650.16 to Dr. William Lee from Allergan (AbbVie) for consulting services is noted. The payment is associated with Ozempic, a drug used for diabetes and weight management. Dr. Lee's specialty is Plastic Surgery, which may or may not align with the primary use of Ozempic.
Patient Guidance: What This Payment Means for You
If you are a patient, discuss any financial relationships your doctor has with pharmaceutical companies with them to ensure transparency in your care. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Consulting fees for plastic surgeons can vary widely, and this payment's context relative to typical compensation for Ozempic-related consulting within this specialty requires further investigation.
Regulatory Context: Sunshine Act Requirements
Payments from pharmaceutical manufacturers to physicians are subject to disclosure under the Sunshine Act, requiring transparency in financial relationships.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharma-payments
- consulting-fees
- plastic-surgery
- allergan
- ozempic
- cms-open-payments
Understanding consulting Payments
Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.
Frequently Asked Questions About This Payment
What was this $4.7K payment for?
This was a consulting payment of $4.7K from Allergan (AbbVie) to William Lee, categorized as "Consulting Fee". It was associated with Ozempic. The payment was reported under the Sunshine Act (CMS Open Payments).
Does William Lee accept pharmaceutical money?
Yes, William Lee received this $4.7K payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view William Lee's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this consulting payment?
A consulting payment of $4.7K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Plastic Surgery?
To compare this payment against Plastic Surgery averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Plastic Surgery physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about William Lee's relationship with Allergan (AbbVie)?
The payment was made for 'Consulting Fee' under the 'consulting' payment type. This $4.7K consulting payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Plastic Surgery?
The date of payment is in the future (August 30, 2025).
What should patients do after learning about this payment?
If you are a patient, discuss any financial relationships your doctor has with pharmaceutical companies with them to ensure transparency in your care.
What else should I know about this consulting payment?
Dr. Lee's NPI is 1795237800.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.